IPGA in association with DCO INDIA DRUGS CONTROL FORUM organized an International Webinar on DESIGNER DRUGS

The webinar was indeed a nourishment to young brains of pharma proffessionals present during the session.

521
Webinar Seminar Laptop computer Online meeting
Picture: Pixabay

Last Updated on April 21, 2022 by The Health Master

The Indian Pharmacy Graduates’ Association National in association with DCO INDIA DRUGS CONTROL FORUM organized an International Webinar entitled “ DESIGNER DRUGS”  A modern day threat of future therapeutic agent, on 17th April, 2022.

The National President Dr. Atul Nasa in his welcome address appreciated such events and expressed. That such events should be continued.

Dr. S. Eswara Reddy, Jt. Drugs Cotroller of India (CDSCO, New Delhi), made his gracious presence available as Chief Guest to bless the young Pharmacy Sauls.

The scientific session was presented by the Key Note Speaker Prof. Muralikrishnan Dhanasekeran, Auburn University (USA).

While addressing a gathering of delegates close to 1000 including Youtube viewers, Prof. Muralikrishnan emphasized on the Designer Drugs and their applicability in Prophylactic, diagnostic and Therapeutic Scales.

He also explained the in silico, invitro and invivo stages in the process of drug design followed by drug synthesis and evaluation.

The event was graced by Lalit Kr Goel, FDA Haryana, Rakesh Dahiya, FDA Haryana S.K. Tiwari, FDA Jharkhand under the leader ship of G. Koteshwar Rao, Telangana, Group Head, DCO India, Drugs Control Forum, Co-ordinator IPGA South Zone and President IPGA Telangana.

Feed back from the delegates was taken and also the session was made open to Questions to make scientific embellishments possible.

The webinar was indeed a nourishment to young brains of pharma proffessionals present during the session.

Session ended with National Anthem and Dr. M.C. Nishit, Kerala has Co Ordinated entaire event.

NPPA expert panel decides not to fix ceiling price of Clotrimazole…

NPPA fixes Retail Price of 15 formulations: April 2022

USFDA gives nod to Lupin for Desvenlafaxine ER tablets

Drug recall: Insulin Glargine recalled due to this reason

DCGI: Fourfold increase in Investigational New Drugs Applications in India

4 Medical Devices Parks to come up in a total of 1,326 acres

CDSCO Committee gives approval to Sun Pharma for Ranibizumab

E-Cigarettes using synthetic nicotine come under FDA oversight

USFDA authorises first C-19 diagnostic test using breath samples

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news